Skip to main content Back to Top


Triamcinolone Hexacetonide Injection

Products Affected - Description

    • Hexatrione injection, Medexus Pharma, 20 mg/mL, 2 mL ampule, 1 count, NDC 59137-0570-01

Reason for the Shortage

    • Sandoz discontinued Aristospan in September 2020.

Available Products

    • There are no presentations available

Estimated Resupply Dates

    • Medexus in conjunction with FDA has had initiated a temporary importation of Triamcinolone Hexacetonide (Hexatrione 2%) injectable suspension 20 mg/mL 2 mL ampules (NDC 59137-0570-01), to the U.S. market to address drug shortage. Currently this product is unavailable to order. Once it is available again, please contact ANDA at1-855-336-3322, Option # 9. There is a side by side comparison between Aristospan and Hexatrione available at


Updated April 8, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created June 22, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.


Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.